TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue18,854,00022,385,00021,903,00019,652,000
Cost of Revenue10,558,00011,703,0009,867,0008,296,000
Gross Profit8,296,00010,682,00012,036,00011,356,000
Operating Expenses
Research Development1,213,0001,778,0002,077,0001,525,000
Selling General and Administrative4,214,0004,846,0004,973,0004,838,000
Non Recurring----
Others-91,00080,00065,000-40,000
Total Operating Expenses15,894,00018,407,00016,982,00014,619,000
Operating Income or Loss2,960,0003,978,0004,921,0005,033,000
Income from Continuing Operations
Total Other Income/Expenses Net-5,627,000-22,360,000-4,089,000-2,802,000
Earnings Before Interest and Taxes2,960,0003,978,0004,921,0005,033,000
Interest Expense-920,000-875,000-546,000-270,000
Income Before Tax-2,667,000-18,382,000832,0002,231,000
Income Tax Expense-195,000-1,933,000521,000634,000
Minority Interest1,087,0001,386,0001,656,000158,000
Net Income From Continuing Ops-2,472,000-16,449,000311,0001,597,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-2,150,000-16,265,000329,0001,588,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-2,399,000-16,525,00068,0001,573,000